BeOne Medicines: Brukinsa And Tevimbra Face A High Bar

BeOne Medicines AG’s oncology growth is fueled by Tevimbra and a deep pipeline, but its premium valuation tempers upside. Click for more on ONC stock.

CryptoAlerta — análise de criptomoedas e mercado em tempo real